6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine

Catalog No. :
ACCRZB265
CAS No. :
133111-56-5
Molecular Formula :
C21H20ClN
Molecular Weight :
321.85

IUPAC Name:6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine

6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$568.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine
IUPAC Name6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine
MDL No.MFCD17015338
Molecular FormulaC21H20ClN
Molecular Weight321.85
SMILESCC1(C)CN2C=C(C(=C2C1)C1=CC=CC=C1)C1=CC=C(Cl)C=C1
InChI KeyRPWLGSCXSKWSCD-UHFFFAOYSA-N
Synonym6-(4-Chlorophenyl)-2,3-Dihydro-2,2-DiMethyl-7-Phenyl-1H-Pyrrolizine;6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine;1H-Pyrrolizine,6-(4-chlorophenyl)-2,3-dihydro-2,2-diMethyl-7-phenyl-
CAS No.133111-56-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACCRZB265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCRZB265 route product structure diagram
    ACCRZB265133111-56-5
Inquiry

2. ACCRZB265 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACHZRV039 route compound structure diagram
    ACHZRV0391679-18-1 In Stock
  4. Then
  5. ACCRZB265 route product structure diagram
    ACCRZB265133111-56-5
Inquiry

Comments (0)